Physician profile
Peter Andrea Beaulieu
NPI 1053750349
$5,445.78
in general payments reported to CMS, 2019-2025
11 companies · $559 in 2025
The $559 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,330 · 2020: $317 · 2021: $967 · 2022: $359 · 2023: $172 · 2024: $1,741 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,496 · Travel and Lodging: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.20 |
| Travel and Lodging | $976.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,314.20 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Endologix LLC | $1,059.33 | 2019-2025 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Cardiovascular Systems INC. | $893.69 | 2019 | |
| Silk Road Medical, INC. | $805.01 | 2021 | |
| Cook Medical LLC | $131.19 | 2019-2020 | |
| Penumbra, INC. | $70.47 | 2021-2022 | |
| Veryan Medical Incorporated | $66.18 | 2021 | |
| Becton, Dickinson and Company | $63.48 | 2025 | Arista |
| Atricure, INC. | $14.57 | 2024 | |
| Baxter Healthcare | $14.42 | 2021 | |
| Smith+Nephew, INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Beaulieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.